Global expansion Klick is rapidly expanding with seven new regional offices outside North America, signaling a growing global footprint and increased capacity to serve multinational life sciences brands with localized commercialization support.

Independent leadership As the world’s largest independent life sciences commercialization partner, Klick offers an attractive proposition for pharma companies seeking unbiased, client-centered services without holding to a holding group agenda.

Strategic acquisitions Recent acquisition of Oxford PharmaGenesis and expansion through Peregrine Market Access enhance scientific-to-commercial capabilities and market access expertise, creating cross-sell opportunities across value, access, and reimbursement segments.

Strong financials Reported revenue in the high hundreds of millions to billions range with significant growth investments from GIC and Linden Capital Partners suggest scale, stability, and funding readiness for larger, multi-market engagements.

Award-winning credibility Recognition as Independent Agency of the Year and Agency of the Year, plus notable revenue milestones, bolster Klick’s credibility when approaching prospective clients about complex lifecycle marketing, digital transformation, and innovative launch strategies.